ADARx Pharmaceuticals, Inc. SEC filings ADRX
ADARx Pharmaceuticals, Inc. has 47 filings in SEC EDGAR's recent list, going back to Feb 6, 2020. The most recent current report (Form 8-K) was filed on Sep 28, 2026 (unregistered share sale, bylaw or fiscal year change, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 16, 2026 | — |
| SCHEDULE 13D | Ownership over 5% (active) | Oct 5, 2026 | — |
| SCHEDULE 13D | Ownership over 5% (active) | Oct 2, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 1, 2026 | — |
| 4 | Insider transaction | Sep 30, 2026 | Sep 28, 2026 |
| 4 | Insider transaction | Sep 30, 2026 | Sep 28, 2026 |
| 4 | Insider transaction | Sep 30, 2026 | Sep 28, 2026 |
| 4 | Insider transaction | Sep 29, 2026 | Sep 28, 2026 |
| 4 | Insider transaction | Sep 29, 2026 | Sep 28, 2026 |
| 4 | Insider transaction | Sep 29, 2026 | Sep 28, 2026 |
| S-8 | Employee stock plan registration | Sep 28, 2026 | — |
| 4 | Insider transaction | Sep 28, 2026 | Sep 24, 2026 |
| 4 | Insider transaction | Sep 28, 2026 | Sep 24, 2026 |
| 4 | Insider transaction | Sep 28, 2026 | Sep 24, 2026 |
| 4 | Insider transaction | Sep 28, 2026 | Sep 24, 2026 |
| 4 | Insider transaction | Sep 28, 2026 | Sep 24, 2026 |
| 8-K |
Current report
Unregistered share sale, Bylaw or fiscal year change, Other events
|
Sep 28, 2026 | Sep 28, 2026 |
| 424B4 | Prospectus | Sep 28, 2026 | — |
| EFFECT | Filing | Sep 24, 2026 | — |
| 3 | Initial insider ownership | Sep 24, 2026 | Sep 24, 2026 |
| 3 | Initial insider ownership | Sep 24, 2026 | Sep 24, 2026 |
| 3 | Initial insider ownership | Sep 24, 2026 | Sep 24, 2026 |
| 3 | Initial insider ownership | Sep 24, 2026 | Sep 24, 2026 |
| 3 | Initial insider ownership | Sep 24, 2026 | Sep 24, 2026 |
| 3 | Initial insider ownership | Sep 24, 2026 | Sep 24, 2026 |
| 3 | Initial insider ownership | Sep 24, 2026 | Sep 24, 2026 |
| 3 | Initial insider ownership | Sep 24, 2026 | Sep 24, 2026 |
| 3 | Initial insider ownership | Sep 24, 2026 | Sep 24, 2026 |
| 3 | Initial insider ownership | Sep 24, 2026 | Sep 24, 2026 |
| 3 | Initial insider ownership | Sep 24, 2026 | Sep 24, 2026 |
| 3 | Initial insider ownership | Sep 24, 2026 | Sep 24, 2026 |
| 3 | Initial insider ownership | Sep 24, 2026 | Sep 24, 2026 |
| S-1MEF | Filing | Sep 24, 2026 | — |
| CERT | Filing | Sep 24, 2026 | — |
| 8-A12B | Filing | Sep 22, 2026 | — |
| S-1/A | Amended registration statement | Sep 21, 2026 | — |
| S-1/A | Amended registration statement | Sep 14, 2026 | — |
| S-1 | Registration statement | Sep 4, 2026 | — |
| DRS/A | Filing | Jul 31, 2026 | — |
| DRS | Filing | Jun 22, 2026 | — |
| D | Filing | Aug 10, 2023 | — |
| D | Filing | Jan 26, 2023 | — |
| D | Filing | Aug 17, 2021 | — |
| D | Filing | May 24, 2021 | — |
| D | Filing | Nov 17, 2020 | — |
| D | Filing | Aug 7, 2020 | — |
| D | Filing | Feb 6, 2020 | — |
Showing 47 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ADRX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1802369
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.